Atlas Trials

Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma

Clinical trial NCT02364206 · COMPLETED

Trial details

NCT number
NCT02364206
Sponsor
Centre Jean Perrin
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Adult Glioblastoma
Start date
2015-06-08
Primary completion
2019-08-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.